Patients report gaps in care and support
Weight-loss responses to GLP-1 obesity drugs, and risks of side effects, may be linked to genetic variants, according to a study conducted by DNA-testing service 23AndMe.
An advanced version of a procedure that uses magnetic fields to stimulate brain nerve cells appears to be extremely effective for combat-related post-traumatic stress disorder, according to a study of active military and veterans.
Doctors should not automatically rule out surgery for octogenarians with early-stage lung cancer, according to a new study that challenges longstanding assumptions about age and cancer treatment and could affect future guidelines.
GLP-1 drugs have direct beneficial effects on the liver, independent of their benefits for obesity, researchers studying the medicines in mice with fatty liver disease have found.
Researchers have developed a modified version of the CRISPR gene-editing tool that in early laboratory experiments suggests it may have the potential to “silence” the extra chromosome that causes Down syndrome.
Advanced genomic testing could help erase significant disparities in breast cancer survival rates between white and Black patients, new research has found.
Twice as many advanced pancreas cancer patients who received an experimental drug developed by Actuate Therapeutics with chemotherapy were alive after one year as those treated with chemo alone, according to results of a mid-stage trial.
An outpatient endoscopic procedure used to treat type 2 diabetes can help prevent people from regaining weight after they discontinue taking GLP-1 drugs, interim results from a clinical trial suggest.
We also report below on early data that poses a possible solution to a devastating pregnancy complication, and a potential breakthrough treatment for liver transplant patients.
